FYERS
Kwality Pharmaceuticals3716.80
-128.10 (-3.33%)

Kwality Pharmaceuticals Share Price

3716.80-128.10 (-3.33%)
+123.55% past 1 Year

Corporate filings & documents

Announcements

Regularization of appointment of Mr Swanith Kapoor as Director and reappointment of Mr Aditya Arora as WTD of the company
2 weeks ago
SCRUTINIZER REPORT OF AGM E-VOTING IS ATTACHED
2 weeks ago
Proceedings of 43rd Annual General Meeting attached herewith.
3 weeks ago
Proceedings of 43rd Annual General Meeting attached herewith.
3 weeks ago
Newspaper Publication of Unaudited Financial Results for the quarter ended June 30 2026.
1 month ago
Newspaper Publication of Unaudited Financial Results for the quarter ended June 30 2026.
1 month ago
Newspaper Publication of Notice of 43rd Annual General Meeting.
1 month ago
Newspaper Publication of Notice of 43rd Annual General Meeting.
1 month ago
Outcome of Investors/Analysts Meeting held on August 10 2026
1 month ago
Outcome of Investors/Analysts Meeting held on August 10 2026
1 month ago
Transcript of Earnings Conference Call - Q1FY27
1 month ago
Transcript of Earnings Conference Call - Q1FY27
1 month ago
Transcript of Earnings Conference Call - Q1FY27
1 month ago
Transcript of Earnings Conference Call - Q1FY27
1 month ago
Investor Presentation for quarter ended June 30 2026.
1 month ago
Investor Presentation for quarter ended June 30 2026.
1 month ago
Financial Results for Quarter Ended June 30 2026.
1 month ago
Financial Results for Quarter Ended June 30 2026.
1 month ago
Submission of standalone and consolidated unaudited financial results for the quarter ended on 30.06.2026 under Regulation 33 of the SEBI (LODR) Regulations 2015
1 month ago
Submission of standalone and consolidated unaudited financial results for the quarter ended on 30.06.2026 under Regulation 33 of the SEBI (LODR) Regulations 2015
1 month ago
NOTICE OF 43RD AGM IS ENCLOSED
1 month ago
Pursuant to Regulations 30 and 34 of the SEBI (LODR) Regulations 2015 as amended ( Listing Regulations) please find attached herewith the Annual Report of the Company for the FY 2025-26 along with Notice convening the 43rd Annual General Meeting ("AGM") of the Company on Monday 31st August 2026 at 12 :00 Noon. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OA VM).
1 month ago
Intimation of Book Closure.
1 month ago
Intimation of Book Closure.
1 month ago
Intimation of 43rd AGM
1 month ago
Intimation of 43rd AGM
1 month ago
This is to inform you pursuant to Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the Board of Directors of the Company at its meeting held today i.e. Saturday August 08 2026 inter alia has taken the following decisions:-1. The Board of Directors of the Company have considered and approved the Report of Board of Directors for the financial year ended as on March 31 2026 under section 134 of the Companies Act 2013.2. The Board of Directors of the Company have considered and approved the Notice of 43rd Annual General Meeting of the Company.3. The Board has approved the day date time and calendar of events and Notice of 43rd Annual General Meeting of the company to be held on 31st August 2026 at 12:00 noon through Video Conferencing (VC)/Other Audio Visual Means (OAVM) * other details as per attachment*
1 month ago
This is to inform you pursuant to Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the Board of Directors of the Company at its meeting held today i.e. Saturday August 08 2026 inter alia has taken the following decisions:-1. The Board of Directors of the Company have considered and approved the Report of Board of Directors for the financial year ended as on March 31 2026 under section 134 of the Companies Act 2013.2. The Board of Directors of the Company have considered and approved the Notice of 43rd Annual General Meeting of the Company.3. The Board has approved the day date time and calendar of events and Notice of 43rd Annual General Meeting of the company to be held on 31st August 2026 at 12:00 noon through Video Conferencing (VC)/Other Audio Visual Means (OAVM) * other details as per attachment*
1 month ago
Intimation of Earnings Conference Call for Q1 FY 2026-27
1 month ago
Intimation of Earnings Conference Call for Q1 FY 2026-27
1 month ago
Intimation of Earnings Conference Call for Q1 FY 2026-27
1 month ago
Intimation of Earnings Conference Call for Q1 FY 2026-27
1 month ago
Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30 2026.
1 month ago
Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30 2026.
1 month ago
Kwality Pharmaceuticals receives CDSCO Nod to Initiate Preclinical Pilot Batches of Pembroluzimab
2 months ago
Kwality Pharmaceuticals receives CDSCO Nod to Initiate Preclinical Pilot Batches of Pembroluzimab
2 months ago
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30-06-2026.
2 months ago
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30-06-2026.
2 months ago
Intimation of Closure of Trading Window
2 months ago
Intimation of Closure of Trading Window
2 months ago
Resignation of Mr. Kartik Kapur Independent Director of the Company.
3 months ago
Resignation of Mr. Kartik Kapur Independent Director of the Company.
3 months ago
Appointment of Mr. Swanith Kapoor as Additional (Non-Executive Independent) Director and Resignation of Mr. Kartik Kapur Independent Director of the Company.
3 months ago
Appointment of Mr. Swanith Kapoor as Additional (Non-Executive Independent) Director and Resignation of Mr. Kartik Kapur Independent Director of the Company.
3 months ago
Annual Secretarial Compliance Report for the year ended 31-03-2026 is enclosed herewith
3 months ago
Audio recording of quarterly earning conference call
3 months ago
Audio recording of quarterly earning conference call
3 months ago
Newspaper Publication of Audited Financial Results for the quarter and year ended March 31 2026.
4 months ago
Newspaper Publication of Audited Financial Results for the quarter and year ended March 31 2026.
4 months ago
Transcript of Earning Conference Call of Q4FY2026.
4 months ago

Annual reports

FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
May 2024
ConcallPresentation
May 2023
ConcallPresentation
May 2022
ConcallPresentation

Kwality Pharmaceuticals Ltd Share Price Today

The Kwality Pharmaceuticals Ltd share price today is ₹3359.90. During the trading session, the Kwality Pharmaceuticals Ltd share price opened at ₹3312.30 and recorded an intraday high of ₹3379.80 and a low of ₹3285.60. Last closing price was ₹3285.50. Over the past 52 weeks, the Kwality Pharmaceuticals Ltd share price has ranged between ₹1561.00 and ₹3744.00. The current Kwality Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.